TY - JOUR
T1 - Specific blockade of basic fibroblast growth factor gene expression in endothelial cells by antisense oligonucleotide
AU - Itoh, Hiroshi
AU - Mukoyama, Masashi
AU - Pratt, Richard E.
AU - Dzau, Victor J.
N1 - Funding Information:
42663, This and work the University is supported Program lRT215. Hiroshi Meyer-Squibb Japan-Stanford of by California NIH grants Tobacco HL35610, Related HL35252, Disease HL Itoh is the recipient of Bristol Fellowship Award.
PY - 1992/11/16
Y1 - 1992/11/16
N2 - The migration and proliferation of endothelial cells play a pivotal role in various vascular diseases. To elucidate the role of endogenous basic fibroblast growth factor (bFGF) produced within endothelial cells on cell growth, we introduced the antisense oligonucleotide complementary to bFGF mRNA into cultured bovine aortic endothelial cells by cationic liposome to block the production of autocrine bFGF. The treatment of the endothelial cells with the specific antisense oligomer efficiently inhibited the synthesis of bFGF with the concomitant suppression of endothelial proliferation, indicating the significant role of bFGF as an endothelial growth promotor. The neutralizing antibody against bFGF had no inhibition on basal DNA synthesis of the endothelial cells, in contrast to marked suppressive action of bFGF antisense oligomer. The results provide the new analytic and therapeutic implications in the use of the antisense methodology for the study of vascular biology.
AB - The migration and proliferation of endothelial cells play a pivotal role in various vascular diseases. To elucidate the role of endogenous basic fibroblast growth factor (bFGF) produced within endothelial cells on cell growth, we introduced the antisense oligonucleotide complementary to bFGF mRNA into cultured bovine aortic endothelial cells by cationic liposome to block the production of autocrine bFGF. The treatment of the endothelial cells with the specific antisense oligomer efficiently inhibited the synthesis of bFGF with the concomitant suppression of endothelial proliferation, indicating the significant role of bFGF as an endothelial growth promotor. The neutralizing antibody against bFGF had no inhibition on basal DNA synthesis of the endothelial cells, in contrast to marked suppressive action of bFGF antisense oligomer. The results provide the new analytic and therapeutic implications in the use of the antisense methodology for the study of vascular biology.
UR - http://www.scopus.com/inward/record.url?scp=0026486808&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026486808&partnerID=8YFLogxK
U2 - 10.1016/0006-291X(92)91359-X
DO - 10.1016/0006-291X(92)91359-X
M3 - Article
C2 - 1445354
AN - SCOPUS:0026486808
SN - 0006-291X
VL - 188
SP - 1205
EP - 1213
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
IS - 3
ER -